跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RUKOBIA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RUKOBIA
Authorized
STANDARD
RUKOBIA
viiv healthcare ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bb39dc5a994ac5c7
Company
viiv healthcare ulc
Type
Standard
Approval Details
Approval Id
bb39dc5a994ac5c7
Drug Approval Canada Name
RUKOBIA
Product Name
RUKOBIA
Status
Marketed
Status Date
2022-04-26
Original Market Date
2022-04-26
Din
02520869
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.08.04
Atc Original
J05AX29 FOSTEMSAVIR
Atc Name
j 05 ax 29
Aig Number
0163177001
Company Name
viiv healthcare ulc
Company Address
1400, 75 Rue Queen, Montreal, Quebec, Canada, H3C 2N6
Active Ingredients
FOSTEMSAVIR (FOSTEMSAVIR TROMETHAMINE)
600 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bb39dc5a994ac5c7
Type
Standard
Back to Health Canada Approvals